Thus, the identification of BRAF as a potential therapeutic target has revolutionized and broadened the spectrum of therapeutic options for melanoma management, with a dramatic impact in survival, while paving the way for contemporary targeted therapy approaches as well for other human malignancies in the era of precision medicine [12]. The gene discussed is BRAF; the disease is melanoma.